Abstract
Chemotherapy is the first line treatment for many cancers; however, it is rarely curative. Despite wide clinical use, it is unclear what distinguishes responders from non-responders and the factors that drive a robust anti-cancer response. This has hindered the identification of predictive biomarkers that can guide clinical decision making as well as the development of new combination treatment strategies. Here, we characterised the tumor microenvironment associated with a complete response to cyclophosphamide chemotherapy; demonstrated that tumors can be sensitised to chemotherapy by inducing a chemo-sensitive phenotype; and investigated the relationship between cyclophosphamide effectiveness and T regulatory cells.
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Thesis sponsors | |
| Award date | 11 Nov 2021 |
| DOIs | |
| Publication status | Unpublished - 2021 |
Access to Document
- THESIS - DOCTOR OF PHILOSOPHY - TILSED, Caitlin Michelle - 2021
This work is protected by Copyright. You may print or download ONE copy of this document for the purpose of your own non-commercial research or study. Any other use requires permission from the copyright owner. The Copyright Act requires you to attribute any copyright works you quote or paraphrase.